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Review of Bovine Virus
Vaccination Related Problems
by Randy Groth*
JW Sexton, DVMt, MS
Bovine virus diarrhea (BVD) was first
recognized in 1946 in the United States and
described as an "X" disease of cattle in the
same year in Canada. It was reported in
Sweden in 1948. In 1953, it was reported by
Ramsey and Chivers as a mucosal disease. 12
When BVD was first recognized, two dif-
ferent conditions were observed and con-
sidered to be different diseases. They were
Virus Diarrhea and Mucosal Disease. Today
it is recognized that all the different condi-
tions of BVD are caused by the same virus of
the virus family Togaviridae and genus
Pestivirus. 3
Today the occurrence of BVD IS
worldwide. It may occur in animals of any
age, but is generally seen in cattle less than a
year of age. In special circumstances it can be
devastating to a herd of older cattle, e.g. ex-
posure of a "closed" dairy herd. The morbidi-
ty of BVD is high serologically but relatively
low clinically. The mortality of the clinical
cases, however, is high. In the United
Kingdom, 50% of the cattle are seropositive,
in Australia 89%, in Germany 87%, and
probably a high percentage in the United
States. 3
BVD virus is a highly infectious agent and
can be transmitted in several ways. Direct
transmission can occur via animal to animal
contact, by oral dosing, or by infection, e.g. a
contaminated syringe. Indirect transmission
can occur through the spread of feces, urine,
or nasal secretions by visitors, trucks, or
possibly other animals. 2 An inapparent car-
rier state also exists in which the animal either
continuously or periodically sheds the BVD
virus. 7,9,13 The incubation period ranges from
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one to three weeks in the field and is generally
around seven days under experimental condi-
tions. 2
BVD will manifest itself in several ways.
Probably the most well known form is as a
mucosal disease and/or an enteritis. Abor-
tion, infertility, interdigital hyperkeratosis,
weak calves, birth defects, and general lack of
condition are also problems encountered with
BVD.
The clinical signs vary widely according to
the form the disease takes. In the classic case,
the animal becomes dull and depressed,
usually with anorexia. Rumen stasis is quite
common, and the animal may experience
mild bloating. As with most viral conditions
there is a marked temperature rise which may
vary from 104°F to 106°F or higher. The
temperature rise may only last one to three
days at which time it returns to normal or one
to two degrees below normal if not com-
plicated by a secondary bacterial infection.
Heart and respiratory rates are usually in-
creased. Two to four days after the onset of
the disease, a watery, profuse, foul-smelling
diarrhea which may contain mucus and blood
begins. The diarrhea is usually very severe
and causes rapid dehydration. In peracute
cases diarrhea may not be present. Oral le-
sions are present in 75% of the cases. They
begin as small petechial hemorrhages and
progress to ulcers or erosions on the lips,
tongue, hard and soft palates, gums, nares,
and the papillae of the mouth, which they
may blunt. In some cases erosions of the cor-
onary and interdigital space may occur. You
may see corneal opacity or abortions also. 2,3, 12
The course of the disease varies from two
to three days to three weeks with a few
animals recovering. Some animals survive,
but never completely recover. In these, one
may see intermittent diarrhea, chronic bloat,
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rough coat, poor doer, hoof deformities,
susceptibility to secondary bacterial infection,
and infertility. 13
The basic lesions of BVD are foci of
degenerating epithelial cells. They develop as
edema and vasculitis below the epithelial sur-
faces and progress to erosions. The necrotic
foci are found in the mouth, on the gums, in
the esophagus (often in a linear arrange-
ment), the forestomachs, the abomasum, and
the small and large intestine. Lymphoid
roecrosis also occurs and may be first evident
in the Peyer's patches of the ileum. The nodes
may become hemorrhagic and necrotic.
Vasculitis may occur in the brain, kidney,
liver, or other organs due to the viremia. 2,3,12
In many cases, other lesions may be found
due to secondary infections. These may be
seen in acute cases, but are more likely in the
chronic ones because of a prolonged im-
munosuppression. The secondary signs many
times can confuse a diagnosis. 20
The mechanism of action of BVD is very
complex and interesting. It causes problems
in identifying carriers, treating the disease,
and even in preventing the disease. Most of
the action is directly or indirectly aimed at the
immune system. Its most constant feature is
its predilection to replicate in and damage
lymphoreticular tissue. This can result in a
significant suppression of the animal's specific
and nonspecific defense mechanisms against
other organisms to which it is simultaneously
exposed. This may allow secondary infec-
tions. Some may be caused by organisms
which are nonpathogenic in other cir-
cumstances. As stated before, the clinical
signs may not even appear as BVD.8
The leukopenia is due in part to BVD's ef-
fect on the lymphocyte. BVD virus has a great
affinity for cells of the immune system, par-
ticularly lymphocytes.5 Some strains of BVD,
like strain C240 (isolated by Gillespie in
Oregon in 1960 from a calf spleen), are
cytopathic. 10 When they infect an animal and
attack its lymphocytes, they rupture and
destroy them. In many cases this causes an
acute disease and death. Most BVD isolates,
however, produce very little or no cytopathic
effect (CPE). In fact, when both a cytopathic
strain and a non-cytopathic strain are in-
oculated together, the cytopathic strain many
times inhibits the non-cytopathic strain. It is
thought that the non-cytopathic virus enters
the lymphocytes and may inhibit DNA and
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RNA synthesis. This inhibition of normal
metabolic function may alter the cells' ability
to undergo blast transformation in response
to oncogenic stimulation. It also interferes
with the cells' ability to exercise their normal
immunologic action. 15 ,16 Lymphocyte
transformation has been shown to be related
to hypersensitivity and cellular immunity
which are important in recovery from a viral
disease. 16
A common occurrence in many fatally in-
fected cattle is a complete failure by the cattle
to develop detectable BVD virus neutralizing
antibodies even though the illness may have
been chronic (several months).15 Their BVD
virus infected lymphocytes may become im-
munologically deficient and permit virus in-
feeted cells to persist for the duration of their
life span.
Some animals seem to be unaffected even
though their lymphocytes are infected by a
noncytopathic BVD virus. In a study of a bull
infected in utero in a National Animal
Disease Center herd, the bull had a persistent
infection throughout his life detected by virus
isolation from the buffy coat of the blood. He
never developed an antibody titer and showed
no ill effects ever during his life. The bull did
persistently shed virus which was pathogenic
to other cattle. 7,20
Although lymphocyte suppression is a
main feature in the pathogenesis of BVD, a
study by Ketelsen et ai. at the University of
Minnesota shows a marked depression of the
normal response of bovine monocytes to a
chemotactic stimulus after these cells are ex-
posed to BVD virus. The alteration of the
monocyte function by BVD virus is very
rapid, showing that the virus can interact
with the monocyte within a few hours after in-
fection. The virus did not cause monocyte
lysis, so it is presumed that it somehow alters
the cellular metabolism. Killed virus had no
effect on the monocytes. Agents which pro-
mote macrophage function, like levamisole,
have been used to prevent monocyte
chemotactic suppression and studies have
shown that it can be used to reverse the sup-
pressive effect of BVD in some cases. 10
The inhibition of neutrophil function is a
third way the immune system is altered. In a
study done at Iowa State by Doctors Roth,
Kaeberle, and Griffith, data indicated that
following BVD infection, a defect occurs in
PMN function. This might be a result of a
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defect in ingestion of particles, degranulation
and the release of lysosomal enzymes into the
phagosome, or an interference with the
myeloperoxidase catalysed reaction. There is
also a significant decrease in the number of
circulating PMN's. PMN morphology by
microscopic examination was not abnormal.
It is thought that this action greatly enhances
BVD virus survival in the host because PMN's
are the most active cell in destroying viral in-
fected cells. 19
Interferon production is also suppressed. 10
This ties in with the other immunologic oc-
currences and may be an important factor in
mixed viral infections with BVD and its role
in the Bovine Respiratory Disease (BRD)
complex.
Since the recognition of BVD virus in
1964, the subject of vaccination has been a
controversial and much debated item. The
vaccine and its effects have been studied by
several groups and individuals with varying,
and at times, totally contradictory results. It
has recently become an item of strong feeling,
both pro and con, in Iowa because of its in-
clusion in the preconditioning program of
calves sponsored by the Iowa Cattleman's
Association and the Iowa AVMA.
Many practitioners strongly recommend
vaccinating for BVD. Some have had no
problems with vaccinating and others think
the benefits obtained outweigh any problems
they might encounter. Many veterinarians
reason that BVD is so widespread today that a
serious problem could arise if they don't vac-
cinate. Vaccinating the cows for BVD has
proven to be a great aid for many dairymen in
raising their calves and preventing the weak
calf syndrome. Some veterinarians even
recommend vaccinating the cow in the last
trimester of gestation for maximum antibody
stimulation in problem herds. S Several feedlot
practitioners strongly recommend vaccinating
cattle upon entry to prevent and decrease the
severity of the BRD Complex.4
On the other hand, some veterinarians
and owners are against vaccinating. Many of
these have had or seen the results of a vaccina-
tion reaction in a herd or individual. Some
are afraid of being caught in the middle of a
bad situation. Some veterinarians feel that
since BVD is so widespread and as there are
still a lot of questions about the vaccine and
BVD itself, vaccination may not be the cor-
rect way to handle it. IS
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The history and clinical signs of vaccine-
related cases are generally the same. Clinical
signs of an illness are usually seen ten to four-
teen days following vaccination. 11 The first
symptoms are anorexia, depression, and an
occulonasal discharge which is serous at first
and then becomes mucoid or mucopurulent.
A crusting of the area around the nose and
eyes may also occur. Oral ulcerations mayor
may not develop at this time. Next comes a
severe watery diarrhea which may contain
mucus and some blood. Intense straining can
also occur. Some of these animals have a high
fever, 104°F plus, while others maintain a
normal temperature. WBC is variable but a
leukopenia of all cell types is the general oc-
currence, especially in the early stages of the
condition. Most animals become severly
dehydrated. Death usually occurs in these
animals in ten to fourteen days. 6 Postmortem
lesions are also variable. Oral and esophageal
ulcers are common as well as ulcers in the
rumen, abdomen, and intestines. Lesions of
Peyers' patches and changes in the spleen and
lymph tissue are seen in over 50% of the
cases. A moderate to severe catarrhal enteritis
may be seen. Evidence of a generalized sep-
ticemia, e.g. petechiation of visceral organs,
may also be found in some cases. 6
After examining the facts, I do not believe
anyone can say we do not see BVD vaccine
related reactions. The cause of these reac-
tions, however, is still a mystery. Several ex-
planations have been proposed. One possibili-
ty is that the vaccine itself causes the condi-
tion directly. Possibly the vaccine is not
modified by enough passages in the
laboratory and it reverts to a somewhat
virulent strain in the animal. Since BVD is so
widespread and can be passed in utero, a non-
cytopathic strain may be harbored in the em-
bryonal bovine kidney cells used to grow the
virus or in the embryonal calf serum used as a
nutrient medium. Virus has been isolated
from several calves at birth without antibody
production. Maybe the working seed virus a
company uses becomes contaminated by a
virulent non-cytopathic virus. 5
It has been shown in several studies that
the vaccine causes a leukopenia and an im-
munosuppression in much the same way as
the natural infection. IS Perhaps this suppres-
sion allows an animal which is incubating a
viral infection, BVD, IBR, etc., to develop
the disease and show clinical signs. The sup-
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pression may also allow a minor or non-
pathogen to establish. Since it is known that
there are inapparent carriers, this may sug-
gest that vaccination stimulates these latent
infections to become clinical cases.
Some people blame the reactions on the
immuno incompetency in some animals. 1
This may be due to individual or hereditary
variation. It could also be due to stress or cor-
ticosteroid treatment. 18
A~ a means to decrease post vaccinal reac-
tions, some companies have switched to grow-
ing the virus on porcine cells to make their
product safer. 17 Others have switched virus
strains or developed new strains of the virus. 5
Several companies are working on killed vac-
cine products at this time. In the past, the
killed products have shown very poor an-
tigenicity and most animals showed no
serological response. 11,14
The duration of immunity to BVD after
vaccination has also been a question. At first
it was thought that it gave a lifelong im-
munity. Today a yearly vaccination is recom-
mended beginning at four to six months1
(earlier if an endemic problem; as young as
one month because maternal antibodies do
not seem to interfere). 18
BVD vaccine should be used with discre-
tion. It can be of great value in many herds. It
should not be given when an animal is under
stress, after corticosteroid therapy, to sick
animals, or with other vaccines, since it does
cause an immunosuppression. I believe we
will see a good killed product in the next few
years and hopefully it will solve the BVD vac-
cination dilemma.
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